(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. (1) Yes ☒ No ☐ (2) Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” accelerated filer” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

State the number of shares outstanding of each of the issuer's classes of common equity, as of August 3,14, 2020 is ~~52,481,507~~54,283,309 common shares.

	March 31,			December 31,			June 30,			December 31,
	2020			2019			2020			2019
	(UNAUDITED)			(AUDITED)			(UNAUDITED)			(AUDITED)
ASSETS

CURRENT ASSETS:
Cash	$	415		$	2,616		$	421		$	2,616
Prepaid expenses and other current assets		7,585			4,335			4,334			4,335
Current assets of discontinued operations		507,774			129,367			-			129,367
Total Current Assets		515,774			136,318			4,755			136,318

OTHER ASSETS
Deposits		-			841			-			841
Non-current assets of discontinued operations		-			517,078			-			517,078
		-			517,919			-			517,919

TOTAL ASSETS	$	515,774		$	654,237		$	4,755		$	654,237

LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES:
Accounts payable and accrued expenses	$	476,592		$	282,705		$	388,778		$	282,705
Convertible notes payable		191,900			264,100			264,300			264,100
Notes payable to related parties		802,328			752,400			-			752,400
Accrued interest on notes payable to related parties		132,077			116,629			-			116,629
Payable to related parties		47,348			35,348			10,525			35,348
Current liabilities of discontinued operations		240,828			160,347			-			160,347
Total Current Liabilities		1,891,073			1,611,529			663,603			1,611,529

LONG-TERM LIABILITY:
Derivative liability		189,653			381,330			237,055			381,330
Long-term liabilities of discontinued operations		-			175,116			-			175,116
Total Long-term Liability		189,653			556,446			237,055			556,446

Total Liabilities		2,080,726			2,167,975			900,658			2,167,975

Commitments and contingencies		-			-			-			-

STOCKHOLDERS' DEFICIT
Common stock, $0.001 par value; 150,000,000 shares authorized; 43,290,324 and 39,583,543 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively		43,291			39,584
Series B Convertible preferred stock, $0.001 par value; 2,000,000 shares authorized; 1,475,000 shares issued and outstanding at June 30, 2020								1,475			-
Common stock, $0.001 par value; 150,000,000 shares authorized; 52,481,499 and 39,583,543 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively								52,482			39,584
Additional paid-in capital		6,857,348			6,706,657			6,915,499			6,706,657
Accumulated deficit		(8,465,591	)		(8,259,979	)		(7,865,359	)		(8,259,979	)
Total Stockholders' Deficit		(1,564,952	)		(1,513,738	)		(895,903	)		(1,513,738	)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	515,774		$	654,237		$	4,755		$	654,237

The accompanying notes are an integral part of these consolidated financial statements.

FOR THE THREE AND SIX MONTHS ENDED ~~MARCH 31,~~JUNE 30, 2020 AND 2019

	Three Months Ended March 31,						Three Months Ended June 30,						Six Months Ended June 30,
	2020			2019			2020			2019			2020			2019


SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
Employee compensation expenses	$	97,304		$	129,135		$	-		$	144,094		$	97,304		$	273,229
General and administrative expenses		68,860			75,640			24,906			30,016			93,766			105,656
		166,164			204,775			24,906			174,110			191,070			378,885

LOSS FROM OPERATIONS		(166,164	)		(204,775	)		(24,906	)		(174,110	)		(191,070	)		(378,885	)

OTHER INCOME (EXPENSE)
Derivative income		122,406			27,180
Derivative income (expense)								(79,894	)		(214,308	)		42,512			(187,128	)
Interest expense		(21,500	)		(20,762	)		(19,255	)		(25,544	)		(40,755	)		(46,306	)
TOTAL OTHER INCOME		100,906			6,418
TOTAL OTHER INCOME (EXPENSE)								(99,149	)		(239,852	)		1,757			(233,434	)

NET LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES		(65,258	)		(198,357	)		(124,055	)		(413,962	)		(189,313	)		(612,319	)
Income taxes		-			-			-			-			-			-

NET LOSS FROM CONTINUING OPERATIONS		(65,258	)		(198,357	)		(124,055	)		(413,962	)		(189,313	)		(612,319	)

INCOME (LOSS) FROM DISCONTINUED OPERATIONS, net of tax		(140,354	)		332
DISCONTINUED OPERATIONS
Loss from discontinued operations								-			(95,952	)		(140,353	)		(95,620	)
Gain on disposal of net assets of discontinued operations								724,286			-			724,286			-
								724,286			(95,952	)		583,933			(95,620	)
NET LOSS	$	(205,612	)	$	(198,025	)
Income taxes								-			-			-			-

INCOME (LOSS) FROM DISCONTINUED OPERATIONS, NET OF TAX								724,286			(95,952	)		583,933			(95,620	)

NET INCOME (LOSS)							$	600,231		$	(509,914	)	$	394,620		$	(707,939	)

NET LOSS PER COMMON SHARE:

Net loss from continuing operations per common share
- basic and diluted	$	(0.00	)	$	(0.01	)
Net loss from continuing operations per common share - basic and diluted							$	(0.00	)	$	(0.01	)	$	(0.00	)	$	(0.02	)

Net loss from discontinued operations per common share	$	(0.00	)	$	0.00
- basic and diluted
Net income from discontinued operations per common share - basic and diluted							$	0.01		$	(0.00	)	$	0.01		$	(0.00	)

NET LOSS PER COMMON SHARE, BASIC AND DILUTED	$	(0.01	)	$	(0.01	)
NET INCOME (LOSS) PER COMMON SHARE, BASIC AND DILUTED							$	0.01		$	(0.02	)	$	0.01		$	(0.03	)

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED		40,510,238			22,130,410			48,617,529			28,008,747			44,745,821			25,353,695

The accompanying notes are an integral part of these consolidated financial statements.

FOR THE ~~THREE~~SIX MONTHS ENDED ~~MARCH 31, 2020 AND~~JUNE 30, 2019

	Common Stock												Common Stock
	Shares		Par Value		Additional Paid-in Capital		Accumulated Deficit			Total			Shares		Par Value		Additional Paid-in Capital		Accumulated Deficit			Total
Balance December 31, 2019 (audited)		39,583,543	$	39,584	$	6,706,657	$	(8,259,979	)	$	(1,513,738	)

Balance December 31, 2018 (audited)														21,813,625	$	21,814	$	5,692,055	$	(6,666,649	)	$	(952,780	)

Common stock issued for services		272,000		272		5,659		-			5,931			4,198,825		4,199		166,858		-			171,057

Common stock issued for conversion of convertible note		3,394,781		3,395		68,805		-			72,200			6,252,940		6,253		167,947		-			174,200

Settlement of derivative liability from conversion of convertible note		-		-		69,271		-			69,271			-		-		230,939		-			230,939

Employee stock plan compensation		40,000		40		6,956		-			6,996			40,000		40		45,378		-			45,418

Common stock issued for cash														760,000		760		90,440		-			91,200

Settlement of payable to related party														200,000		200		7,800		-			8,000

Settlement of notes payable and accrued interest with related party														3,074,592		3,075		119,909		-			122,984

Cumulative adjustments from adoption of ASC 842														-		-		-		(4,402	)		(4,402	)

Net loss								(205,612	)		(205,612	)		-		-		-		(707,939	)		(707,939	)

Balance March 31, 2020 (unaudited)		43,290,324	$	43,291	$	6,857,348	$	(8,465,591	)	$	(1,564,952	)
Balance June 30, 2019 (unaudited)														36,339,982	$	36,341	$	6,521,326	$	(7,378,990	)	$	(821,323	)

The accompanying notes are an integral part of these consolidated financial statements.

FOR THE ~~THREE~~SIX MONTHS ENDED ~~MARCH 31,~~JUNE 30, 2020 ~~AND 2019~~

The accompanying notes are an integral part of these consolidated financial statements.

Acacia Diversified Holdings, Inc. (“Acacia” or the “Company”), a Texas corporation, had four wholly-owned subsidiaries, MariJ Pharmaceuticals, Inc. (“MariJ Pharma”), a Florida corporation, Canna-Cures Research & Development Center, Inc. (“Canna-Cures”), a Florida corporation, ~~and~~ Eufloria Medical of Tennessee, Inc. (“EMT”), a company incorporated in the state of ~~Tennessee. In July 2018, the Company also announced the completion of its acquisition of~~Tennessee, and Medahub Operations Group, Inc. and Medahub, Inc., technology companies ~~(“Medahub”~~(collectively “Medahub”) incorporated in the state of ~~Florida, complete with a current compounding pharmacy license in~~ Florida. The Medahub acquisition allowed the Company to be fully HIPAA compliant and cloud based on an HL7 platform. The Company planned to offer licensing agreements for other cannabis companies wanting to be HIPAA compliant from left to right or seed to sale and doctor to patient.

The Company’s primary source of revenue was from the extraction of medicinal hemp oil, from a non-psychoactive cannabis plant. All extraction services were provided in states where such services were deemed legal. The Company's subsidiary EMT was invited to be part of the hemp pilot program in ~~Tennessee. This program~~Tennessee which provided the Company the license to grow, manufacture, and dispense organic hemp oil in Tennessee. ~~The Company planned on participating in this pilot program through its new, wholly-owned subsidiary.~~

The Company also had a retail store in Tennessee selling hemp infused products. Revenue generated from retail sales was not ~~expected to be~~ material to the Company based on ~~current~~its operating model.

On March 26, 2020, the Company announced in a current report on Form 8-k that its operations and business have experienced disruption due to the unprecedented conditions surrounding the COVID-19 pandemic spreading throughout the United States and the world and thus the Company’s business operations have been disrupted and it was unable to timely prepare the Company’s financial statements for the 2019 fiscal year. As such, the Company would be making use of the 45-day grace period provided by the SEC’s Order and available filing extension to delay filing of its Annual Report. Around this time, the Company also suspended its operations, laid off all of its employees and ceased to generate any revenue.

On March 31, 2020, Richard K. Pertile resigned his position as Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer for the Company. On the same date, the Company filed a current report on Form 8-k to announce that it issued in escrow 1,475,000 shares of the Company’s Series B Convertible Preferred Stock (the “Preferred Stock”) to ORCIM Financial Holdings, LLC (“OFH”). Each share of the Preferred Stock has fifty (50) votes per share and may be converted into fifty (50) $0.001 par value common shares. As of March 31, 2020, the Company had 43,290,324 shares of its common stock issued and outstanding. There were no other shares of any capital stock outstanding except for the common stock and Preferred Stock. As the result of the issuance of the Preferred Stock and, upon satisfaction of the terms of the Acquisition Agreement, OFH would have voting control over the Company with 73,750,000 votes on all matters submitted to stockholders for a vote. The parties agree that the change in control would not be effective until all conditions of the Acquisition Agreement are satisfied, including, but not limited to, the acquisition of funding by OFH to satisfy certain debts of the Company and the resignation of its existing board of directors. On May 20, 2020, the Company’s existing board of directors resigned.

Pursuant to the terms of the Acquisition Agreement, the parties agree that the Company will transfer to Richard K. Pertile (“Pertile”), our former CEO, all the issued and outstanding shares of each of the Company’s wholly-owned subsidiaries, and Pertile agreed to forgive all amounts due him or his related parties from the Company. The forgiveness of debt was approximately $910,000 and the value of the net assets of the subsidiaries was approximately $267,000 (net of $240,000 of liabilities). The Acquisition Agreement also specified which accounts payable, accrued liabilities and convertible notes would remain as liabilities of the Company. OFH has agreed to the payment of the following liabilities:

As of the date of the issuance of the consolidated financial statements, the Company settled professional fees in the amount of $110,000 and other liabilities remained outstanding.

OFH is a limited liability company domiciled in Maryland. OFH is controlled by Mr. Jeffery D. Bearden, who owns 100% of the membership interests of OFH. The Preferred Stock was acquired by OFH in exchange for its agreement to assume the debt of the Company in the approximate amount of ~~$450,000.~~$666,000. The funds to satisfy the outstanding debt of the Company were acquired by OFH through a loan from a hedge fund entity known as Geneva Capital.

On March 31, 2020, Mr. Larnell C. Simpson, Jr., was appointed as a director for Acacia Diversified Holdings, Inc. (the “Company”). Mr. Simpson also was appointed to the position of Vice President.

On May 20, 2020, directors Danny Gibbs, Neil B. Gholson and Dr. Richard Paula each resigned their respective positions as a director for Acacia Diversified Holdings, Inc.

Based on operating losses and negative cash from operations and the discontinued operations of the Company’s operations, substantial doubt exists about the Company’s ability to continue as a going concern. Management’s plan in this regard is to find new operations to enter into and focus on building profitable operations. To finance operations while it finds new operations, the Company will continue financing activity such as entering into loan agreements and issuing new shares of the Company’s common stock. Therefore, the Company expects to continue to incur operating losses and to incur professional fees to maintain its reporting company status. Until such time that the Company is able to generate revenue and become profitable or find new sources of capital, the Company will find it difficult to continue to meet its obligations as they come due. There can be no assurance that the Company will be successful in its efforts to raise capital, or if it were successful in raising capital, that it would be successful in meeting its business plans. Management’s plans include attempting to raise funds from the public through an equity offering of the Company’s common stock and identifying and developing new opportunities. However, the recent COVID-19 pandemic has presented unprecedented challenges to businesses and the investing landscape around the world. Therefore, there can be no assurance that Management’s plans will be successful.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses for all periods presented and has a substantial accumulated deficit. As of ~~March 31,~~June 30, 2020, these factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

The accompanying consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and reflect all adjustments, which consist solely of normal recurring adjustments, needed to fairly present the financial results for these periods. The consolidated financial statements and notes thereto are presented as prescribed by Form 10-Q. Accordingly, certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted. The accompanying consolidated financial statements should be read in conjunction with the financial statements for the fiscal year ended December 31, 2019 and notes thereto in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the Securities and Exchange Commission on June 26, 2020. Operating results for the three and six months ended ~~March 31,~~June 30, 2020 are not necessarily indicative of the results that may be expected for the entire fiscal year. In the opinion of management, all adjustments have been made, which consist only of normal recurring adjustments necessary for a fair statement of (a) the results of operations for the three-month ~~period~~and six-month periods ended ~~March 31,~~June 30, 2020 and 2019, (b) the financial position at ~~March 31,~~June 30, 2020 and (c) cash flows for the three-month ~~period~~and six-month periods ended ~~March 31,~~June 30, 2020 and 2019.

As a result of the insufficient cash flows from the operations of our subsidiaries as well as the disruption of our business from the COVID-19 pandemic, as of March 31, 2020, the Company discontinued the operations of all of its wholly-owned subsidiaries. The financial results for these subsidiaries have been presented as discontinued operations in the accompanying consolidated financial statements. For the ~~three~~six months ended ~~March 31,~~June 30, 2020 and 2019, all gains and losses on disposition, impairment charges and disposal costs, along with the sales, costs and expenses and income taxes attributable to discontinued operations, have been aggregated in a single caption entitled “Income (loss) from discontinued operations, net of tax” in our consolidated statements of operations for all periods presented.

The consolidated financial statements include the accounts of Acacia Diversified Holdings, Inc. and its wholly-owned subsidiaries, MariJ Pharmaceuticals, Inc, Canna-Cures Research & Development Center, Inc., Eufloria Medical of Tennessee, Inc., Medahub Operations Group, Inc. and Medahub, Inc., as of and for the three months ended March 31, 2020. All significant intercompany accounts and transactions are eliminated in consolidation. As a result of the insufficient cash flows from the operations of our subsidiaries as well as the disruption of our business from the COVID-19 pandemic, as of March 31, 2020, the Company discontinued the operations of all of its wholly-owned subsidiaries. The financial results for these subsidiaries have been presented as discontinued operations in the accompanying consolidated financial statements. For the ~~three~~six months ended ~~March 31,~~June 30, 2020, ~~and 2019,~~ all gains and losses on disposition, impairment charges and disposal costs, along with the sales, costs and expenses and income taxes attributable to discontinued operations, have been aggregated in a single caption entitled “Income (loss) from discontinued operations, net of tax” in our consolidated statements of operations for all periods presented.

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The actual results may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Certain accounts in the prior period's financial statements have been reclassified for comparative purposes to conform with the presentation in the current year financial statements.

In July 2018, the Company announced the completion of its acquisition of Medahub Operations Group, Inc. and Medahub, Inc., technology companies (“Medahub”), which includes a current compounding pharmacy license in Florida. The Medahub acquisition allows the Company to be fully HIPAA compliant and cloud based on an HL7 platform. The Company can now offer licensing agreements for other cannabis companies wanting to be HIPAA compliant from left to right or seed to sale and Doctor to Patient. The Company issued 600,000 shares of its restricted common stock to the principal of Medahub as consideration of the acquisition, valued at $126,000.

When determining the accounting of the acquisition, the Company concluded that the acquisition does not constitute the acquisition of a business since there was no inputs, processes or outputs within Medahub. In addition, although the Company acquired certain software and technology from Medahub, the most significant asset it acquired was Medahub's principal's commitment to provide support, guidance and direction for implementing this technology. Without the principal's commitment of his time, the Company will not be able to implement the technology and begin generating cash flows. Therefore, the Company believes that the value of the purchase is concentrated on the service provided by Medahub's principal. As a result, the Company allocated the entire purchase price to the service provided and accounted for it as professional fee expense.

As of March 31, 2020, the Company discontinued the operations of Medahub and presented its assets, liabilities and results of operations as part of discontinued operations in the consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02, Leases, which aims to make leasing activities more transparent and comparable and requires substantially all leases be recognized by lessees on their balance sheet as a right-of-use asset and corresponding lease liability, including leases currently accounted for as operating leases. The new guidelines are contained in Accounting Standards Codification ASC Topic 842 - Leases ("ASC 842"). This ASU is effective for all interim and annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company applied this standard retrospectively on January 1, 2019 through a cumulative effect adjustment recognized as of January 1, 2019. In applying this standard, the Company elects to apply all practical expedients to not reassess the followings:

In addition, in the applying ASC 842, the Company does not elect the hindsight practical expedient.

As a result, the Company recorded its right-of-use assets and corresponding lease liabilities on its balance sheet beginning January 1, 2019. As of March 31, 2020, the Company discontinued the operations of its subsidiaries and presented the right-of-use assets and related liabilities and results of operations as part of discontinued operations in the consolidated financial statements.

The Company recognizes its office lease in Florida with an initial term of 12 months or less as a short-term lease. Lease payments associated with short-term lease are expensed as incurred in operating lease expense and are not included in our calculation of right-of-use assets or lease liabilities. Operating lease expense related to short-term lease was $0 and $2,899 for the three months ended June 30, 2020 and 2019, respectively, and $4,199 and $5,794 for the six months ended June 30, 2020 and 2019. This short-term lease was terminated in July 2020.

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which replaces numerous requirements in U.S. GAAP, including industry specific requirements, and provides a single revenue recognition model for recognizing revenue from contracts with customers. The Company adopted this standard effective January 1, 2018.

The core principle of the new standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This requires companies to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenues from extraction activities and from retail sales are recognized at a point in time.

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenues.

The two permitted transition methods under the new standard are the full retrospective method, in which case the standard would be applied to each prior reporting period presented and the cumulative effect of applying the standard would be recognized at the earliest period shown, or the modified retrospective method, in which case the cumulative effect of applying the standard would be recognized at the date of initial application to accumulated deficit. Additionally, incremental footnote disclosures are required to present the 2018 revenues under the prior standard. Under the modified retrospective method, an entity may also elect to apply the standard to either (i) all contracts as of January 1, 2018, or (ii) only to contracts that are not completed as of January 1, 2018. The Company elected to adopt this guidance using the modified retrospective method at January 1, 2018 which did not result in an adjustment to accumulated deficit. Additionally, upon adoption, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.

As of March 31, 2020, the Company discontinued the operations of its subsidiaries and presented the results of operations of the subsidiaries as part of discontinued operations in the consolidated financial statements.

The Company’s accounts receivable represents amounts due from customers for extraction services performed. Allowance for uncollectible accounts receivable is estimated based on the aging of the accounts receivable and management estimate of uncollectible amounts. At ~~March 31,~~June 30, 2020 and December 31, 2019, the Company did not provide for an allowance for doubtful accounts. As of March 31, 2020, the Company discontinued the operations of its subsidiaries and presented its accounts receivable as asset of discontinued operations in the consolidated financial statements.

Inventories are stated at the lower of cost or market. Cost is determined using the average cost method. The Company’s inventory consists of raw materials and finished goods. Cost of inventory includes cost of ingredients, labor, quality control and all other costs incurred to bring our inventories to condition ready to be sold. As of March 31, 2020, the Company discontinued the operations of its subsidiaries and presented its inventories as assets of discontinued operations in the consolidated financial statements.

The Company's subsidiary EMT grows hemp plants in both its indoor and outdoor facility. In accordance with Accounting Standards Codification 905 - Agriculture, all direct and indirect costs of growing the plants are accumulated until the time of harvest. These deferred cost cannot exceed the realizable value of the oil processed from the hemp plants. Crop costs such as soil preparation incurred before planting are deferred and allocated to the growing crop. Deferred farm expense is included as inventory costs. As of March 31, 2020, the Company discontinued the operations of its subsidiaries and presented its deferred farm expense as asset of discontinued operations in the consolidated financial statements.

The Company incurred debt discount related to the issuance of convertible promissory notes, as described in Note 6. The discount was recognized in its entirety as interest expense rather than amortized over the life of the convertible promissory note. The immediate recognition did not yield materially different result.

The Company incurred direct costs associated with the issuance of convertible promissory notes, as described in Note 6. The Company recognized these costs as interest expense.

The Company accounts for stock-based compensation under Accounting Standards Codification 718 - Compensation-Stock Compensation (“ASC 718”). ASC 718 requires that all stock-based compensation be recognized as expense in the financial statements and that such cost be measured at the fair value of the award at the grant date and recognized over the period during which an employee is required to provide services (requisite service period). An additional requirement of ASC 718 is that estimated forfeitures be considered in determining compensation expense. Estimating forfeitures did not have a material impact on the determination of compensation expense during the ~~three~~six months ended ~~March 31,~~June 30, 2020 and 2019.

The Company accounts for stock based awards based on the fair market value of the instrument using a 10-day volume weighted adjusted price (VWAP) and accounts for stock options issued using the Black-Scholes option pricing model and utilizing certain assumptions including the followings:

Risk-free interest rate – This is the yield on U.S. Treasury Securities posted at the date of grant (or date of modification) having a term equal to the expected life of the option. An increase in the risk-free interest rate will increase compensation expense.

Expected life—years – This is the period of time over which the options granted are expected to remain outstanding. Options granted by the Company had a maximum term of ten years. An increase in the expected life will increase compensation expense.

Expected volatility – Actual changes in the market value of stock are used to calculate the volatility assumption. An increase in the expected volatility will increase compensation expense.

Dividend yield – This is the annual rate of dividends per share over the exercise price of the option. An increase in the dividend yield will decrease compensation expense. The Company does not currently pay dividends and has no immediate plans to do so in the near future.

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of Accounting Standards Codification 505-50, Equity – Based Payments to Non-Employees. Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The value of the common stock is measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty’s performance is complete.

During the ~~three~~six months ended ~~March 31,~~June 30, 2020, the board of directors approved the following issuances of the Company’s restricted common stock to consultants, employees, and directors for services rendered:

FAIR VALUE ESTIMATES – The Company measures assets and liabilities it acquires at fair value in accordance with Accounting Standards Codification 820 – Fair Value Measurement (“ASC 820”). The objective of ASC 820 is to increase consistency and comparability in fair value measurements and to expand disclosures about fair value measurements. ASC 820 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 specifies a valuation hierarchy based on whether the inputs to those valuation techniques are observable or unobservable.

Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions. These two types of inputs have created the following fair value hierarchy:

This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when estimating fair value. The Company has liability measured at fair value on a recurring basis due to the issuance of convertible note payable as described in Note 6.

NET INCOME (LOSS) PER SHARE - In accordance with ASC 260 - Earnings Per Share, the basic income per common share is computed by dividing the net income available to common stockholders by the weighted average common shares outstanding during the period. Diluted earnings per share reflect per share amounts that would have resulted if diluted potential common stock had been converted to common stock. No dilutive potential common shares were included in the computation of diluted net income per share for all periods presented because their impact was anti-dilutive. As of June 30, 2020, the Company had 20,000 options outstanding, 1,475,000 shares of Series B convertible preferred stock and $264,300 of outstanding convertible notes payable which were excluded from the computation of net income per share because they are anti-dilutive for the three and six months ended June 30, 2020. As of June 30, 2019, the Company had 50,000 options outstanding and $124,800 of outstanding convertible notes payable which were excluded from the computation of net income per share because they are anti-dilutive for the three and six months ended June 30, 2019.

The Company entered into the following promissory notes payable to its former CEO during the year ended December 31, 2019 and during the ~~three~~six months ended ~~March 31,~~June 30, 2020:

Note Date		Note Balance 12/31/18		New Loan		Note Conversion			Note Balance 12/31/19		New Loan		Note Conversion		Note Balance 3/31/2020			Note Balance 12/31/18		New Loan		Note Conversion			Note Balance 12/31/19		New Loan		Note Conversion		Amounts Settled (See NOTE 9)			Note Balance 6/30/2020

September 2017		$	558,400	$	-	$	-		$	558,400	$	-	$	-	$	558,400		$	558,400	$	-	$	-		$	558,400	$	-	$	-	$	(558,400	)	$	-
March 2018			72,000		-		(72,000	)		-		-		-		-			72,000		-		(72,000	)		-		-		-					-
April 2018			42,000		-		(42,000	)		-		-		-		-			42,000		-		(42,000	)		-		-		-					-
August 2018			70,000		-		-			70,000		-		-		70,000			70,000		-		-			70,000		-		-		(70,000	)		-
November 2018			20,000		-		-			20,000		-		-		20,000			20,000		-		-			20,000		-		-		(20,000	)		-
December 2018			50,000		-		-			50,000		-		-		50,000			50,000		-		-			50,000		-		-		(50,000	)		-
May 2019	(1)		-		10,000		-			10,000		-		-		10,000	(1)		-		10,000		-			10,000		-		-		(10,000	)		-
June 2019	(2)		-		25,000		-			25,000		-		-		25,000	(2)		-		25,000		-			25,000		-		-		(25,000	)		-
December 2019	(3)		-		19,000		-			19,000		-		-		19,000	(3)		-		19,000		-			19,000		-		-		(19,000	)		-
February 2020	(4)		-		-		-			-		40,000		-		40,000	(4)		-		-		-			-		40,000		-		(40,000	)		-
March 2020	(5)		-		-		-			-		9,928		-		9,928	(5)		-		-		-			-		9,928		-		(9,928	)		-
																-
		$	812,400	$	54,000	$	(114,000	)	$	752,400	$	49,928	$	-	$	802,328		$	812,400	$	54,000	$	(114,000	)	$	752,400	$	49,928	$	-	$	(802,328	)	$	-

Note Date		Accrued Interest 12/31/18		Interest Expense		Interest Conversion			Accrued Interest 12/31/19		Interest Expense		Interest Conversion		Accrued Interest 3/31/2020			Accrued Interest 12/31/18		Interest Expense		Interest Conversion			Accrued Interest 12/31/19		Interest Expense		Interest Conversion		Amounts Settled (See NOTE 9)			Accrued Interest 6/30/2020

September 2017		$	56,544	$	44,672	$	-		$	101,216	$	11,137	$	-	$	112,353		$	56,544	$	44,672	$	-		$	101,216	$	22,274	$	-	$	(123,490	)	$	-
March 2018			4,402		7,196		(11,598	)		-		-		-		-			4,402		8,632		(13,034	)		-		-		-		-			-
April 2018			2,333		4,198		(6,531	)		-		-		-		-			2,333		5,035		(7,368	)		-		-		-		-			-
August 2018			2,169		5,600		-			7,769		1,396		-		9,165			2,169		5,600		-			7,769		2,792		-		(10,561	)		0
November 2018			184		1,600		-			1,784		399		-		2,183			184		1,600		-			1,784		798		-		(2,582	)		(0	)
December 2018			142		4,000		-			4,142		997		-		5,140			142		4,000		-			4,142		1,995		-		(6,137	)		(0	)
May 2019	(1)		-		508		-			508		199		-		708	(1)		-		508		-			508		399		-		(907	)		0
June 2019	(2)		-		1,134		-			1,134		499		-		1,633	(2)		-		1,134		-			1,134		997		-		(2,132	)		(0	)
December 2019	(3)		-		75		-			75		379		-		454	(3)		-		75		-			75		758		-		(833	)		(0	)
February 2020	(4)		-		-		-			-		403		-		403	(4)		-		-		-			-		1,201		-		(1,201	)		0
March 2020	(5)		-		-		-			-		39		-		39	(5)		-		-		-			-		237		-		(237	)		(0	)

		$	65,774	$	68,983	$	(18,129	)	$	116,629	$	15,448	$	-	$	132,077		$	65,774	$	71,257	$	(20,402	)	$	116,629	$	31,451	$	-	$	(148,080	)	$	(0	)

(1) In May 2019, the Company entered into an unsecured promissory note agreement with its former CEO and his spouse, in the amount of $10,000. The promissory note bears interest at a rate of 8% per annum. The principle balance and accrued interest is due 90 days from the date of the note. The Company accrued interest on these notes in the amount of ~~$708~~$907 through ~~March 31,~~June 30, 2020.

(2) In June 2019, the Company entered into an unsecured promissory note agreement with its former CEO and his spouse, in the amount of $25,000. The promissory note bears interest at a rate of 8% per annum. The principle balance and accrued interest is due 90 days from the date of the note. The Company accrued interest on these notes in the amount of ~~$1,633~~$2,132 through ~~March 31,~~June 30, 2020.

(3) In December 2019, the Company entered into an unsecured promissory note agreement with its former CEO and his spouse, in the amount of $19,000. The promissory note bears interest at a rate of 8% per annum. The principle balance and accrued interest is due 90 days from the date of the note. The Company accrued interest on these notes in the amount of ~~$454~~$833 through ~~March 31,~~June 30, 2020.

(4) In February 2020, the Company entered into an unsecured promissory note agreement with one of its former director, in the amount of $40,000. The promissory note bears interest at a rate of 8% per annum. The principle balance and accrued interest is due 30 days from the date of the note. The Company accrued interest on these notes in the amount of ~~$403~~$1,201 through ~~March 31,~~June 30, 2020.

(5) In March 2020, the Company entered into two unsecured promissory notes agreements with its former CEO and his spouse, in the amounts of $2,500 and $7,428. The promissory notes bear interest at a rate of 8% per annum. The principle balance and accrued interest is due 30 days from the dates of the notes. The Company accrued interest on these notes in the amount of ~~$39~~$237 through ~~March 31,~~June 30, 2020.

As a result, the total principle amount of notes payable to related parties from continuing operations was $802,328 and $752,400, at ~~March 31,~~June 30, 2020 and December 31, 2019, respectively. Accrued interest on these notes payable to related parties from continuing operations was ~~$132,077~~$148,080 and $116,629, at ~~March 31,~~June 30, 2020 and December 31, 2019, respectively. The note balances and accrued interest on June 30, 2020 were settled when the Company disposed of its discontinued operations as described in Note 9.

Payable to related parties from continuing operations consisted of the followings at ~~March 31,~~June 30, 2020 and December 31, 2019:

	March 31,		December 31,
	2020		2019		June 30, 2020			December 31, 2019
Short term loan from related entity (1)	$	35,348	$	26,348	$	-		$	35,348
Receivable from related party for issuance of Series B Convertible Preferred Stock						(1,475	)		-
Auto allowances owed to former CEO (2)		12,000		9,000		12,000			-
Payable to Related Parties from continuing operations	$	47,348	$	35,348	$	10,525		$	35,348

(1) In 2017, the Company received a working capital advance of $74,348 from a related entity. These advances are non-interest bearing and were intended as short term capital advances. The remaining balances have been included in payable to related parties as current liabilities on the consolidated balance sheets at ~~March 31,~~June 30, 2020 and December 31, 2019.

(2) On May 1, 2016, the Company entered into an employment agreement with its former CEO. The term of the employment iswas through December 31, 2019. The agreement provided for a monthly automobile allowance of $1,000 to the former CEO.

In May 2019, the board of directors approved issuance of 200,000 shares of the Company's restricted common stock to the Company's former CEO to settle the accrued automobile allowance expense in the amount of $8,000. AsThe Company assumed the liability of the automobile allowance that was previously a ~~result, $12,000 and $9,000 remained owed to the Company’s CEO at March 31, 2020 and December 31, 2019, respectively.~~subsidiary’s liability.

During the three months ended ~~March 31,~~June 30, 2020 and 2019, expenses from continuing operations related to the automobile allowances totaled $0 and $3,000, respectively. During the six months ended June 30, 2020 and 2019, expenses from continuing operations related to the automobile allowances totaled $3,000 and $6,000, respectively.

Accounts payable and accrued expenses of continuing operations consisted of the followings at ~~March 31,~~June 30, 2020 and December 31, 2019:

	March 31, 2020		December 31, 2019		June 30, 2020		December 31, 2019
Accounts payable to vendors	$	145,661	$	965	$	58,843	$	965
Payroll taxes payable		65,414		63,206		65,414		63,206
Accrued salaries and bonuses		247,992		207,062		247,992		207,062
Accrued interest on notes payable		17,525		11,472		16,529		11,472
Accounts payable and accrued expenses of continuing operations	$	476,592	$	282,705	$	388,778	$	282,705

On June 13, 2019, the Company issued a convertible promissory note ("Note 3") for $93,500. Note 3 was discounted at $85,000 and the Company received net proceeds of $82,000 after incurring $3,000 of debt issuance costs. The note bears an interest rate at 10% per annum, and principal and accrued interest is due on the maturity date of June 13, 2020. The conversion option price associated with the note has a 25% discount to the market price of the stock. The market price is based on the average of the two lowest trading prices during a ten day period prior to conversion. The note is convertible at any time. As a result of the variable feature associated with the conversion option, pursuant to ASC Topic 815, the Company bifurcated the conversion option, and utilized the Black Scholes valuation model to determine the fair value of the conversion option. At the issuance date, the Company recorded a derivative expense and derivative liability of $151,264. At the end of each reporting period, the Company revalued the derivative liability and recorded the change in this value as additional derivative expense. The Company recognized ~~$35,005~~$33 and $0$35,039 as derivative income for the three and six months ended ~~March 31,~~June 30, 2020, respectively. The Company recognized $120,573 as derivative expense for the three and ~~2019, respectively.~~six months ended June 30, 2019. The derivative liability was valued at $7,652 at March 31, 2020. As of ~~March 31,~~June 30, 2020, the ~~holder~~entire note principle balance of ~~Note 3~~$93,500 was converted ~~principle amount of $84,200 of the note to 3,644,781~~into 5,468,310 shares of the Company’s common stock. The note holder also converted $4,250 of accrued interest into 1,102,941 shares of the Company’s common stock. As a result of the conversion, the derivative liability was extinguished at June 30, 2020.

On July 12, 2019, the Company issued a convertible promissory note ("Note 4") for $91,300. Note 4 was discounted at $83,000 and the Company received net proceeds of $80,000 after incurring $3,000 of debt issuance costs. The note bears an interest rate at 10% per annum, and principal and accrued interest is due on the maturity date of July 12, 2020. The conversion option price associated with the note has a 25% discount to the market price of the stock. The market price is based on the average of the two lowest trading prices during a ten day period prior to conversion. The note is convertible at any time. As a result of the variable feature associated with the conversion option, pursuant to ASC Topic 815, the Company bifurcated the conversion option, and utilized the Black Scholes valuation model to determine the fair value of the conversion option. At the issuance date, the Company recorded a derivative expense and derivative liability of $117,886. At the end of each reporting period, the Company revalued the derivative liability and recorded the change in this value as additional derivative expense. The Company recognized ~~$46,675~~$29,042 and $0$75,717 as derivative income for the three and six months ended ~~March 31,~~June 30, 2020, ~~and 2019,~~ respectively. The derivative liability was valued at ~~$83,158~~$29,244 and $129,833 at ~~March~~June 30, 2020 and December 31, ~~2020.~~2019, respectively.

On October 10, 2019, the Company issued a convertible promissory note ("Note 5") for $91,300. Note 5 was discounted at $83,000 and the Company received net proceeds of $80,000 after incurring $3,000 of debt issuance costs. The note bears an interest rate at 10% per annum, and principal and accrued interest is due on the maturity date of October 10, 2020. The conversion option price associated with the note has a 25% discount to the market price of the stock. The market price is based on the average of the two lowest trading prices during a ten day period prior to conversion. The note is convertible at any time. As a result of the variable feature associated with the conversion option, pursuant to ASC Topic 815, the Company bifurcated the conversion option, and utilized the Black Scholes valuation model to determine the fair value of the conversion option. At the issuance date, the Company recorded a derivative expense and derivative liability of $128,642. At the end of each reporting period, the Company revalued the derivative liability and recorded the change in this value as additional derivative expense. The Company recognized ~~$40,725~~$29,668 and $0$70,393 as derivative income for the three and six months ended ~~March 31,~~June 30, 2020, ~~and 2019,~~ respectively. The derivative liability was valued at ~~$98,843~~$69,175 and $139,568 at ~~March~~June 30, 2020 and December 31, 2019, respectively.

On May 21, 2020, the Company issued a convertible promissory note ("Note 6") for $103,000. The note holder disbursed the net proceeds of $103,000 to pay various professional fees on behalf of the Company. The note bears an interest rate at 12% per annum, and principal and accrued interest is due on the maturity date of May 21, 2021. The conversion option price associated with the note has a 39% discount to the market price of the stock. The market price is based on the average of the two lowest trading prices during a ten day period prior to conversion. The note is convertible at any time. As a result of the variable feature associated with the conversion option, pursuant to ASC Topic 815, the Company bifurcated the conversion option, and utilized the Black Scholes valuation model to determine the fair value of the conversion option. At the issuance date, the Company recorded a derivative expense and derivative liability of $480,598. At the end of each reporting period, the Company revalued the derivative liability and recorded the change in this value as additional derivative expense. The Company recognized $138,637 as derivative expense for the three and six months ended June 30, 2020, respectively. The derivative liability was valued at $138,686 at June 30, 2020.

Liability measured at fair value on a recurring basis by level within the fair value hierarchy as of ~~March 31,~~June 30, 2020 and December 31, 2019 is as follows:

	Fair Value Measurement at March 31, 2020 (1) Using Level 2								Fair Value Measurement at June 30, 2020 (1) Using Level 2
	Note 3		Note 4		Note 5		Total		Note 4		Note 5		Note 6		Total
Liability:
Derivative liability	$	7,652	$	83,158	$	98,843	$	189,653	$	29,244	$	69,175	$	138,636	$	237,055
Total liability	$	7,652	$	83,158	$	98,843	$	189,653	$	29,244	$	69,175	$	138,636	$	237,055

(1) The Company did not have any assets or liabilities measured at fair value using Level 1 or 3 of the fair value hierarchy as of ~~March 31,~~June 30, 2020 and December 31, 2019.

The Company’s derivative liabilities are classified within Level 2 of the fair value hierarchy. The Company utilizes the Black-Scholes valuation model to value the derivative liabilities utilizing observable inputs such as the Company’s common stock price, the conversion price of the conversion option, and expected volatility, which is based on historical volatility. The Black-Scholes valuation model employs the market approach in determining fair value.

The following is a reconciliation of the beginning and ending balances for liabilities measured at fair value on a recurring basis during the ~~three~~six months ended ~~March 31,~~June 30, 2020 and the year ended December 31, 2019:

	Note 1			Note 2			Note 3			Note 4			Note 5			Total
Balance at December 31, 2018	$	138,218		$	58,300		$	-		$	-		$	-		$	196,518		$	138,218		$	58,300		$	-		$	-		$	-		$	-		$	196,518
Variable conversion feature in convertible notes payable		-			-			151,264			117,886			128,642			397,792			-			-			151,264			117,886			128,643			-			397,793
Change in fair value		58,502			14,250			(25,489	)		11,947			10,926			70,136			58,502			14,250			(25,489	)		11,947			10,926			-			70,136
Conversion of derivative liability to equity from note conversion		(196,719	)		(72,550	)		(13,847	)		-			-			(283,117	)		(196,719	)		(72,550	)		(13,847	)		-			-			-			(283,117	)
Balance at December 31, 2019		-			(0	)		111,928			129,833			139,568			381,329		$	-		$	(0	)	$	111,928		$	129,833		$	139,569		$	-		$	381,330
Variable conversion feature in convertible notes payable		-			-			-			-			-			-			-			-			-			-			-			480,598			480,598
Change in fair value		-			-			(35,005	)		(46,675	)		(40,725	)		(122,405	)		-			-			(35,038	)		(75,716	)		(70,392	)		(341,961	)		(523,108	)
Conversion of derivative liability to equity from note conversion		-			-			(69,271	)		-			-			(69,271	)		-			-			(76,890	)		(24,873	)		-			-			(101,763	)
Balance at March 31, 2020	$	-		$	(0	)	$	7,652		$	83,158		$	98,843		$	189,653
Balance at June 30, 2020																			$	-		$	(0	)	$	-		$	29,244		$	69,175		$	138,636		$	237,055

Since the issuance of Note 3, the note holder elected to convert the entire note principle ~~amount of $84,200 of Note 3~~and accrued interest into the Company's common stock on the following dates, at the respective conversion prices, resulting in the following number of shares issued to the note holder:

Date of Conversion of Note 3	Amounts Converted		Conversion Price		Number of Shares Issued		Amounts Converted		Conversion Price		Number of Shares Issued
Principle conversion
December 23, 2019	$	12,000	$	0.0480		250,000	$	12,000	$	0.0480		250,000
January 6, 2020	$	15,000	$	0.0465		322,581	$	15,000	$	0.0465		322,581
January 27, 2020	$	15,000	$	0.0338		443,787	$	15,000	$	0.0338		443,787
February 4, 2020	$	20,000	$	0.0338		591,716	$	20,000	$	0.0338		591,716
March 6, 2020	$	22,200	$	0.0109		2,036,697	$	22,200	$	0.0109		2,036,697
April 1, 2020							$	9,300	$	0.0051		1,823,529

							$	93,500				5,468,310
Accrued interest conversion
April 1, 2020							$	1,500	$	0.0051		294,118
May 7, 2020							$	2,750	$	0.0034		808,824

Total amount converted	$	84,200				3,644,781	$	97,750				6,571,251

Since the issuance of Note 4, the note holder elected to convert $21,300 of principle balance into the Company's common stock on the following dates, at the respective conversion prices, resulting in the following number of shares issued to the note holder:

The Company's board of directors is authorized by the Article of Incorporation to issue 2,000,000 shares of preferred stock at $0.001 par value, in one or more series. In August 2019, the Company's board of directors designated and authorized the issuance of 1,475,000 shares of Series B Convertible Preferred Stock (the “Preferred Stock”). Each share of ~~series B preferred stock~~Preferred Stock will have 50 votes per share and may be converted into 50 $0.001 par value common stock. The holders of ~~series B preferred stock~~the Preferred Stock are entitled to receive, when and if as declared by the board of directors, cumulative dividends payable in cash. The board of directors set the dividend rate on each share of Preferred Stock at 0%. The holders of ~~series B preferred stock~~Preferred Stock are also given preference over common stock holders in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company and subject and subordinate to the rights of secured creditors of the Company.

As a result of a change in control, on March 31, 2020, the Company issued in escrow 1,475,000 shares of the Company’s Series B Convertible Preferred Stock (the “Preferred Stock”) to ORCIM Financial Holdings, LLC (“OFH”). Each share of the Preferred Stock has fifty (50) votes per share and may be converted into fifty (50) $0.001 par value common shares. As of ~~March 31,~~June 30, 2020, the Company had ~~43,290,324~~52,481,499 shares of its common stock issued and outstanding. There were no other shares of any capital stock outstanding except for the common stock and Preferred Stock. As the result of the issuance of the Preferred Stock and, upon satisfaction of the terms of the Acquisition Agreement, OFH would have voting control over the Company with 73,750,000 votes on all matters submitted to stockholders for a vote. The parties agree that the change in control would not be effective until all conditions of the Acquisition Agreement are satisfied, including, but not limited to, the acquisition of funding by OFH to satisfy certain debts of the Company and the resignation of its existing board of directors. On May 20, 2020, the Company’s existing board of directors resigned.

The Company has been authorized to issue 150,000,000 shares of common stock, $.001 par value. Each share of issued and outstanding common stock shall entitle the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution.

During the ~~three~~six months ended ~~March 31,~~June 30, 2020, the Company issue ~~3,706,781~~12,897,956 shares of its restricted common stock as follows:

At ~~March 31,~~June 30, 2020, 20,000 options were outstanding and there were no warrants outstanding. The Company did not issue any common stock purchase warrants or options during the ~~three~~six months ended ~~March 31,~~June 30, 2020 and 2019.

In March 2017, the board of directors approved issuance of 100,000 shares of the Company’s restricted common stock to its key employees. The award is subject to a four or five-year vesting requirements, i.e. the requisite service period. The shares are issued as the vesting restriction lapses. The Company valued these shares at fair value on commitment date which is the date on which the employee accepted the award and recorded stock based compensation expense over the requisite service period. ~~Stock~~As a result of winding down its operations, the Company laid off all its employees as of March 31, 2020. As such, stock based compensation expense for these awards for the three months ended ~~March 31,~~June 30, 2020 and 2019 was $0 and $8,116, respectively, and $6,996 and ~~$9,102,~~$20,402 for the six months ended June 30, 2020 and 2019, respectively.

At ~~March 31,~~June 30, 2020, the Company owed its former CEO $103,845 of unpaid salary, $52,500 of accrued bonus and $12,000 of unpaid automobile allowance. The employment agreement was renewed through June 30, 2020 at an annual salary of $150,000 and continued to provide for a monthly automobile allowance of $1,000. The employment agreement was effectively terminated as a result of the change in control but these amounts remained outstanding as part of the Company’s continuing operations.

At ~~March 31,~~June 30, 2020, the Company owed its former COO $12,085 of unpaid salary and $79,562 of accrued bonus. The employment agreement was renewed through June 30, 2020 at an annual salary of $96,000. The employment agreement was effectively terminated as a result of the change in control but these amounts remained outstanding as part of the Company’s continuing operations.

In August 2016, the Company entered into a licensing agreement to use exclusively a brand name for one of its discontinued subsidiary’s products for five years. Pursuant to the terms of the agreement, the Company issued 2,000 shares of its restricted common stock to the brand owner at the beginning of the agreement and 2,000 shares at the end of each of the next four years. At ~~March 31,~~June 30, 2020, there remains 2,000 shares to be issued to the brand owner.

On March 31, 2020, Richard K. Pertile resigned his position as Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer for the Company. On the same date, the Company filed a current report on Form 8-k to announce that it issued in escrow 1,475,000 shares of the Company’s Series B Convertible Preferred Stock (the “Preferred Stock”) to ORCIM Financial Holdings, LLC (“OFH”). Each share of the Preferred Stock has fifty (50) votes per share and may be converted into fifty (50) $0.001 par value common shares. As of March 31, 2020, the Company had 43,290,331 shares of its common stock issued and outstanding. There were no other shares of any capital stock outstanding except for the common stock and Preferred Stock. As the result of the issuance of the Preferred Stock and, upon satisfaction of the terms of the Acquisition Agreement, OFH would have voting control over the Company with 73,750,000 votes on all matters submitted to stockholders for a vote. The parties agree that the change in control would not be effective until all conditions of the Acquisition Agreement are satisfied, including, but not limited to, the acquisition of funding by OFH to satisfy certain debts of the Company and the resignation of its existing board of directors. On May 20, 2020, the Company’s existing board of directors resigned.

Pursuant to the terms of the Acquisition Agreement, the parties agree that the Company will transfer to Richard K. Pertile (“Pertile”), our former CEO, all the issued and outstanding shares of each of the Company’s wholly-owned subsidiaries and Pertile agreed to forgive all amounts due him or his related parties from the Company. The forgiveness of debt was approximately $910,000 and the value of the net assets of the subsidiaries was approximately $267,000 (net of $240,000 of liabilities). The Acquisition Agreement also specified which accounts payable, accrued liabilities and convertible notes would remain as liabilities of the Company. OFH has agreed to the payment of the followings:

As of the date of the issuance of the consolidated financial statements, the Company settled professional fees in the amount of $110,000 and other liabilities remained outstanding.

In accordance with the provisions of ASC 205-20, the Company has separately reported the assets and liabilities of the discontinued operations in the consolidated balance sheets. The assets and liabilities ~~have been reflected~~were presented as assets and liabilities of discontinued operations in the consolidated balance sheets as of March 31, 2020 and December 31, 2019. These assets and liabilities were disposed of during the three months ended June 30, 2020 and resulted in a gain on disposition of $724,286.

Assets and liabilities of discontinued operations as of December 31, 2019 ~~and consist~~consisted of the following:

The Company’s inventories of the discontinued operations consisted of the followings at ~~March 31,~~June 30, 2020 and December 31, 2019:

	March 31, 2020			December 31, 2019		June 30, 2020			December 31, 2019
Raw materials	$	32,294		$	32,294	$	32,294		$	32,294
Finished goods (isolates, tinctures, capsules, etc.)		13,392			13,903		13,392			13,903
Inventory valuation allowance		(15,000	)		-		(15,000	)		-
							30,686			46,197
Inventory disposed of during the three months ended June 30, 2020							(30,686	)		-
Inventory of discontinued operations	$	30,686		$	46,197	$	-		$	46,197

As a result of suspending its operations and the increasingly competitive market for its products, the Company provided a valuation allowance of $15,000 to reduce the cost of its inventory to its estimated net realizable value.

Property and equipment of the discontinued operations consisted of the followings at ~~March 31,~~June 30, 2020 and December 31, 2019:

	03/31/2020			12/31/2019			June 30, 2020			December 31, 2019
Computer equipment	$	7,582		$	7,582		$	7,582		$	7,582
Website		7,000			7,000			7,000			7,000
Furniture & equipment		557,273			557,273			557,273			557,273
Farm equipment		52,295			52,295			52,295			52,295
Farm improvement		61,495			61,495			61,495			61,495
Leasehold improvement		82,008			82,008			82,008			82,008
Total property and equipment		767,653			767,653			767,653			767,653
Less accumulated depreciation		(454,548	)		(417,144	)		(454,548	)		(417,144	)
								313,105			350,509
Property and equipment disposed of during the three months ended June 30, 2020								(313,105	)		-
Net property and equipment of discontinued operations	$	313,105		$	350,509		$	-		$	350,509

Depreciation expense from discontinued operations for the three months ended ~~March 31,~~June 30, 2020 and 2019 were $0 and $4792, respectively, and $37,404 and ~~$36,901,~~$41,693 for the six months ended June 30, 2020 and 2019, respectively.

The Company recognizes its office lease in Florida with an initial term of 12 months or less as a short-term lease. Lease payments associated with short-term lease are expensed as incurred in operating lease expense and are not included in our calculation of right-of-use assets or lease liabilities. Operating lease expense for discontinued operations related to short-term lease was $4,199 and $2,895 for the three months ended March 31, 2020 and 2019, respectively. This short-term lease was terminated in July 2020.

The Company entered into a lease agreement to lease its retail space in Tennessee in October 2017 with a lease term of 24 months. The lease contains a renewal option to extend the term for two additional years. The lease expired on November 30, 2019 and the Company notified the landlord that it would not renew the lease. Rent for the discontinued operations for the first twelve months was $2,500 per month and $2,550 for the next twelve months. In applying ASC 842, the Company uses a lease term of 24 months and an incremental borrowing rate of 5.99% which was the borrowing rate on a finance lease (discussed below).

The board of directors approved for the Company to enter into a lease to lease this property from the Company's former CEO, effective June 1, 2018. The term of the lease was for one year with an automatic renewal term of one year. The lease also contained an option for the Company to purchase the property from the Company's former CEO. The lease required the Company to pay all expenses related to the acquisition and operation of the property, including but not limited to the Company's former CEO's personal incremental borrowing costs, repairs and maintenance, real estate taxes, licenses and permits, utilities, etc.

ROU asset - finance lease - land	$	37,530		$	37,530
ROU asset - finance lease - improvement		148,787			148,787
ROU asset - finance lease obtained in exchange for lease liability - finance lease		186,317			186,317
Cumulative effect adjustment to ROU asset - finance lease on adoption date		(8,679	)		(8,679	)
Amortization of ROU asset - finance lease		(18,598	)		(18,598	)
ROU asset - finance lease at March 31, 2020	$	159,040
					159,040
ROU asset – finance lease disposed of during the three months ended June 30, 2020					(159,040	)
ROU asset – finance lease of discontinued operations				$	-

Lease liability - finance lease on adoption date	$	186,318		$	186,318
Cumulative effect adjustment to ROU lease liability - finance lease on adoption date		(4,277	)		(4,277	)
Payments on lease liability - finance lease		(10,981	)		(10,981	)
Lease liability - finance lease on March 31, 2020	$	171,060
					171,060
Lease liability – finance lease disposed of during the three months ended June 30, 2020					(171,060	)
Lease liability – finance lease of discontinued operations				$	-

Interest expense related to lease liability - finance lease was ~~$2,515~~$0 and ~~$2,643~~$2,633 for the three months ended ~~March 31,~~June 30, 2020 and 2019, respectively, and $2,515 and $5,256 for the six months ended June 30, 2020 and 2019, respectively.

Variable lease expense was $0 and $11,513 for the three months ended June 30, 2020 and 2019, respectively, and $9,671 and $19,233 for the six months ended June 20, 2020 and 2019, respectively.

Accounts payable and accrued expense of discontinued operations consisted of the followings at ~~March 31,~~June 30, 2020 and December 31, 2019:

	March 31, 2020		December 31, 2019		June 30, 2020			December 31, 2019
Accounts payable to vendors	$	113,560	$	31,218	$	113,560		$	31,218
Accounts payable and accrued expenses	$	113,560	$	31,218
						113,560			31,218
Accounts payable and accrued expenses disposed of during the three months ended June 30, 2020						(113,560	)		-
Accounts payable and accrued expenses of discontinued operations					$	-		$	31,218

In June 2018, the Company entered into a financing agreement to finance the purchase of a farm tractor for its discontinued operations. The financing agreement was secured by the tractor. The total amount financed was $21,794 at 0% interest per annum. The first monthly payment of $363 began in July 2018 and continued for 60 months. The following is the total payment amounts for the next four years:

Twelve Months ending March 31,
Twelve Months ending			June 30,			December 31,
2020			$	-		$	4,359
2021	$	4,359		4,359			4,359
2022		4,359		4,359			4,359
2023		4,359		4,359			2,143
2024		1,053		1,053			-
	$	14,130		14,130			15,220
Long-term debt disposed of during the three months ended June 30, 2020				(14,130	)		-
Long-term debt of discontinued operations			$	-		$	15,220

			June 30, 2020			December 31, 2019
Amount of principle due in the next 12 months	$	4,359	$	4,359		$	4,359
Long term portion of principle due		9,771		9,771			10,861
				14,130			15,220
Long-term debt disposed of during the three months ended June 30, 2020				(14,130	)		-
Total principle amounts due from discontinued operations	$	14,130	$	-		$	15,220

Payable to related parties from continuing operations consisted of the followings at ~~March 31,~~June 30, 2020 and December 31, 2019:

(a) In 2017, the Company received a working capital advance of $74,348 from a related entity. These advances are non-interest bearing and were intended as short term capital advances. The remaining balances have been included in payable to related parties as current liabilities of discontinued operations on the consolidated balance sheets at ~~March 31,~~June 30, 2020 and December 31, 2019.

In January 2020, the Company’s former CEO provided a short term advance in the amount of $18,000 for working capital for the discontinued operations. The Company repaid the advance to the former CEO in the same month.

In accordance with the provisions of ASC 205-20, we have not included the results of operations from discontinued operations in the results of continuing operations in the consolidated statements of operations. The results of operations from discontinued operations for the three and six months ended ~~March 31,~~June 30, 2020 ~~and 2019,~~ have been reflected as discontinued operations in the consolidated statements of operations. The results of operations from discontinued operations for the three and six months ended ~~March 31, 2020 and~~June 30, 2019 ~~and consist~~consisted of the following:

	Three Months Ended March 31, 2020			Three Months Ended March 31, 2019			Three Months Ended June 30, 2019			Six Months Ended June 30, 2019

REVENUE	$	1,622		$	163,505		$	140,724		$	304,229

COSTS OF GOODS SOLD
Costs of goods sold		73,220			48,742			132,569			181,311
Depreciation expense		36,883			23,457			36,844			73,229
		110,103			72,199			169,413			254,540

GROSS PROFIT (LOSS)		(108,481	)		91,306			(28,689	)		49,689

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
Employee compensation expenses		1,805			29,105			20,491			49,596
General and administrative expenses (7)		22,263			44,146			43,637			87,783
Depreciation and amortization expense		4,241			17,163			4,241			8,476
		28,309			90,414			68,369			145,855

INCOME (LOSS) FROM DISCONTINUED OPERATIONS		(136,790	)		892
LOSS FROM DISCONTINUED OPERATIONS								(97,058	)		(96,166	)

OTHER INCOME (EXPENSE)
Interest expense		(3,221	)		(2,643	)		(2,613	)		(5,256	)
Other income (expense)		(343	)		2,083			3,719			5,802
TOTAL OTHER EXPENSE		(3,564	)		(560	)
TOTAL OTHER INCOME								1,106			546

NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS BEFORE INCOME TAXES		(140,354	)		332
NET LOSS FROM DISCONTINUED OPERATIONS								(95,952	)		(95,620	)
Income taxes		-			-			-			-

NET INCOME (LOSS) FROM DISCONTINUED OPERATIONS, net of tax	$	(140,354	)	$	332
NET LOSS FROM DISCONTINUED OPERATIONS, net of tax							$	(95,952	)	$	(95,620	)

The board of directors approved for the Company to enter into a lease to lease this property from the Company's former CEO, effective June 1, 2018. The term of the lease was for one year with an automatic renewal term of one year. The lease required the Company to pay all expenses related to the acquisition and operation of the property, including but not limited to the Company's former CEO's personal incremental borrowing costs, repairs and maintenance, real estate taxes, licenses and permits, etc. For the three months ended ~~March 31,~~June 30, 2020 and 2019, the Company incurred ~~$9,864~~$0 and ~~$7,720,~~$11,513, respectively, in operating expenses of discontinued operations for this ~~property.~~

~~MARCH 31,~~property, and $9,864 and $19,233, for the six months ended June 30, 2020

The Company evaluated subsequent events through the date the financial statements were issued, and determined that there were no other material events to disclose, other than the followings:

On May 20, 2020, the Company announced that it had entered into an Acquisition Agreement and Plan of Share Exchange (“Acquisition Agreement”) with its former CEO Richard K. Pertile, its former board of directors, OFH and its managing member Jeff Bearden. Richard K. Pertile resigned his position as Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer for the Company, effective March 31, 2020. On the same date, the Company filed a current report on Form 8-k to announce that it issued in escrow 1,475,000 shares of the Company’s Series B Convertible Preferred Stock (the “Preferred Stock”) to ORCIM Financial Holdings, LLC (“OFH”). Each share of the Preferred Stock has fifty (50) votes per share and may be converted into fifty (50) $0.001 par value common shares. As of March 31, 2020, the Company had 43,290,324 shares of its common stock issued and outstanding. There were no other shares of any capital stock outstanding except for the common stock and Preferred Stock. As the result of the issuance of the Preferred Stock and, upon satisfaction of the terms of the Acquisition Agreement, OFH would have voting control over the Company with 73,750,000 votes on all matters submitted to stockholders for a vote. The parties agree that the change in control would not be effective until all conditions of the Acquisition Agreement are satisfied, including, but not limited to, the acquisition of funding by OFH to satisfy certain debts of the Company and the resignation of its existing board of directors. On May 20, 2020, the Company’s existing board of directors resigned.

Pursuant to the terms of the Acquisition Agreement, the parties agree that the Company will transfer to Richard K. Pertile (“Pertile”), our former CEO, all the issued and outstanding shares of each of the Company’s wholly-owned subsidiaries and Pertile agreed to forgive all amounts due him or his related parties from the Company. The forgiveness of debt was approximately $910,000 and the value of the net assets of the subsidiaries was approximately $267,000 (net of $240,000 of liabilities). The Acquisition Agreement also specified which accounts payable, accrued liabilities and convertible notes would remain as liabilities of the Company. OFH has agreed to the payment of the followings:

~~As of the date of the issuance of the consolidated financial statements, the Company settled professional fees in the amount of $110,000 and other liabilities remained outstanding.~~

~~On May 20, 2020, directors Danny Gibbs, Neil B. Gholson and Dr. Richard Paula each resigned their respective positions as a director for Acacia Diversified Holdings, Inc.~~

On May 21, 2020, the Company issued a convertible promissory note ("Note 6") for $103,000. Note 6 was issued to settle professional fees due at a result of the change in control. The note bears an interest rate at 12% per annum, and principal and accrued interest is due on the maturity date of May 21, 2021. The conversion option price associated with the note has a 39% discount to the market price of the stock. The market price is based on the lowest trading price during a twenty day period prior to conversion. The note is convertible beginning on the 180^th day following the date of the note. As a result of the variable feature associated with the conversion option, pursuant to ASC Topic 815, the Company will bifurcate the conversion option, and utilize the Black Scholes valuation model to determine the fair value of the conversion option.

Subsequent to ~~March 31,~~June 30, 2020, the holder of our convertible notes converted ~~the remaining principle balance~~$20,000 of ~~Note 3 in the amount of $9,300 and accrued interest of $2,750 into 2,926,471 shares of the Company’s common stock. In addition, the holder of our convertible notes converted the~~ principle balance of Note 4 in the amount of ~~$21,300~~ into ~~6,264,705~~1,801,802 shares of the Company’s common stock.

We regularly monitor our compliance with applicable financial reporting standards and review new pronouncements and drafts thereof that are relevant to us. As a result of new standards, changes to existing standards and changes in their interpretation, we might be required to change our accounting policies, particularly concerning revenue recognition, the capitalized incremental costs to obtain a customer contract and lease accounting, to alter our operational policies and to implement new or enhance existing systems so that they reflect new or amended financial reporting standards, or to restate our published financial statements. Such changes may have an adverse effect on our business, financial position, and operating results, or cause an adverse deviation from our revenue and operating profit target, which may negatively impact our financial results.

Accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements, other than the followings.

The Security and Exchange Commission ("SEC") recently amended its rules to require an analysis of changes in stockholders’ equity in the financial statements included in quarterly reports on Form 10-Q. The analysis, which can be presented as a note or separate statement, is required for the current and comparative quarter and year-to-date interim periods. The amended rules will become effective 30 days after they are published in the Federal Register. The SEC's transition guidance states that the amendments are effective for all filings made on or after the effective date; however, it also states the SEC staff would not object if a filer’s first presentation of the changes in stockholders’ equity was included in its Form 10-Q for the quarter that begins after the effective date of the amendments. As such, the Company presented an analysis of changes in stockholders' deficit as a separate statement in this Form 10-Q.

Except as noted above and in our Form 10-K, the Company’s management does not believe that recent codified pronouncements by the Financial Accounting Standards Board (“FASB”) (including its EITF), the AICPA or the SEC will have a material impact on the Company’s current or future consolidated financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) contains forward-looking statements within the meaning of the Private Litigation Reform Act of 1995 that involve known and unknown risks, significant uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, or implied, by those forward-looking statements. You can identify forward-looking statements by the use of the words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “seeks”, “estimates”, “may”, “will”, “should”, “could”, “predicts”, “potential”, “proposed”, or “continue” or the negative of those terms. These statements are only predictions. In evaluating these statements, you should consider various factors which may cause our actual results to differ materially from any forward-looking statements. Although we believe that the exceptions reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements due to numerous factors, including, but not limited to, availability of financing for operations, successful performance of operations, impact of competition and other risks detailed below as well as those discussed elsewhere in this Form 10-Q and from time to time in the Company’s Securities and Exchange Commission filings and reports. In addition, general economic and market conditions and growth rates could affect such statements. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

These unaudited interim consolidated financial statements should be read in conjunction with the annual financial statements for the Company most recently completed fiscal year ended December 31, 2019. These unaudited interim consolidated financial statements do not include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended December 31, 2019.

~~Prior to March 31, 2020,~~Acacia Diversified Holdings, Inc. (“Acacia” or the ~~Company~~“Company”), a Texas corporation, had four wholly-owned subsidiaries, MariJ Pharmaceuticals, Inc. (“MariJ Pharma”), a Florida corporation, Canna-Cures Research & Development Center, Inc. (“Canna-Cures”), a Florida corporation, ~~and~~ Eufloria Medical of Tennessee, Inc. (“EMT”), a company incorporated in the state of ~~Tennessee. In July 2018, the Company also announced the completion of its acquisition of~~Tennessee, and Medahub Operations Group, Inc. and Medahub, Inc., technology companies ~~(“Medahub”~~(collectively “Medahub”) incorporated in the state of ~~Florida, complete with a current compounding pharmacy license in~~ Florida.

The Company’s primary source of revenue was from the extraction of medicinal hemp oil, from a non-psychoactive cannabis plant. All extraction services were provided in states where such services were deemed legal. The Company's subsidiary EMT was invited to be part of the hemp pilot program in Tennessee which provided the Company the license to grow, manufacture, and dispense organic hemp oil in Tennessee. The Company also had ~~a hemp farm and~~ a retail store in Tennessee ~~growing, manufacturing and~~ selling hemp infused products. Revenue generated from retail sales was not material to the Company based on its operating model.

On March 26, 2020, the Company announced in a current report on Form 8-k that its operations and business have experienced disruption due to the unprecedented conditions surrounding the COVID-19 pandemic spreading throughout the United States and the world and thus the Company’s business operations have been disrupted and it was unable to timely review and prepare the Company’s financial statements for the 2019 fiscal year. As such, the Company would be making use of the 45-day grace period provided by the SEC’s Order and available filing extension to delay filing of its Annual Report. Around this time, the Company also suspended its operations, laid off all of its employees and ceased to generate any revenue.

On March 31, 2020, Richard K. Pertile resigned his position as Chairman of the Board of Directors, Chief Executive Officer and Chief Financial Officer for the Company. On the same date, the Company filed a current report on Form 8-k to announce that it issued in escrow 1,475,000 shares of the Company’s Series B Convertible Preferred Stock (the “Preferred Stock”) to ORCIM Financial Holdings, LLC (“OFH”). Each share of the Preferred Stock has fifty (50) votes per share and may be converted into fifty (50) $0.001 par value common shares. As of March 31, 2020, the Company had ~~43,290,331~~43,290,324 shares of its common stock issued and outstanding. There were no other shares of any capital stock outstanding except for the common stock and Preferred Stock. As the result of the issuance of the Preferred Stock and, upon satisfaction of the terms of the Acquisition Agreement, OFH would have voting control over the Company with 73,750,000 votes on all matters submitted to stockholders for a vote. The parties agree that the change in control would not be effective until all conditions of the Acquisition Agreement are satisfied, including, but not limited to, the acquisition of funding by OFH to satisfy certain debts of the Company and the resignation of its existing board of directors. On May 20, 2020, the Company’s existing board of directors resigned.

Pursuant to the terms of the Acquisition Agreement, the parties agree that the Company will transfer to Richard K. Pertile (“Pertile”), our former CEO, all the issued and outstanding shares of each of the Company’s wholly-owned subsidiaries and Pertile agreed to forgive all amounts due him or his related parties from the Company. The forgiveness of debt was approximately $910,000 and the value of the net assets of the subsidiaries was approximately $267,000 (net of $240,000 of liabilities). The Acquisition Agreement also specified which accounts payable, accrued liabilities and convertible notes would remain as liabilities of the Company. OFH has agreed to the payment of the followings:

As of the date of the issuance of the consolidated financial statements, the Company settled professional fees in the amount of $110,000 and other liabilities remained outstanding.

On May 20, 2020, directors Danny Gibbs, Neil B. Gholson and Dr. Richard Paula each resigned their respective positions as a director for Acacia Diversified Holdings, Inc.

Operating results for the three months ended ~~March 31,~~June 30, 2020 and ~~2019~~:2019:

For the three months ended ~~March 31,~~June 30, 2019, selling, general and administrative expenses were ~~$204,775,~~$174,110, compared to ~~$166,164~~$24,906 during the three months ended ~~March 31,~~June 30, 2020, a decrease of ~~$38,611~~$149,204 or ~~19%~~86%. The decrease in these expenses is ~~primarily attributable~~a result of the Company winding down its operations and laid off its workforce.

During the three months ended June 30, 2019, the Company incurred interest expense of $25,544, compared to an$19,255 for the three months ended June 30, 2020, a decrease ~~in salaries and wages for our former CEO and COO~~of $6,289, or 25%. Interest expense decreased because a related party settled certain outstanding balances of his notes through issuance of the Company’s common stock, therefore, reducing the overall balance of the notes during the current period.

During the three months ended June 30, 2019, the Company recognized $214,308 of derivative expense, compared to $79,894 derivative expense for the three months ended June 30, 2020, a decrease of $134,414, or 63%. The increase in the amount of outstanding convertible notes payable with variable conversion feature that gave rise to derivative liability, coupled with the reduction in our share price during the current period gave rise to the decrease of the derivative expense.

As a result of the changes described above, the Company incurred a net loss from continuing operations of $413,962 for the three months ended June 30, 2019, compared to a net loss from continuing operations of $124,055 for the three months ended June 30, 2020, the loss decreased by $289,907, or 70%.

For the three months ended June 30, 2019, the Company’s subsidiaries generated revenues of $140,724 from operations and incurred costs of goods sold of $169,413. As a result, the Company’s subsidiaries gross loss was $28,689.

For the three months ended June 30, 2019, selling, general and administrative expenses were $68,369. The Company’s subsidiaries also incurred interest expense of $2,613 and earned other income of $3,719.

As a result of the changes in revenues, costs and expenses, the Company’s subsidiaries incurred net loss from discontinued operations of $95,952 for the three months ended June 30, 2019.

The Company discontinued its subsidiaries operations on March 31, 2020. Therefore, there was no operations to report for the three months ended June 30, 2020.

For the six months ended June 30, 2019, selling, general and administrative expenses were $378,885, compared to $191,070 during the six months ended June 30, 2020, a decrease of $187,815 or 50%. The decrease in these expenses is primarily attributable to the Company winding down its operations and laid off its workforce during the current period.

During the six months ended June 30, 2019, the Company incurred interest expense of ~~$20,762,~~$46,306, compared to ~~$21,500~~$40,755 for the ~~three~~six months ended ~~March 31,~~June 30, 2020, a decrease of $5,551, or 12%. Interest expense decreased because a related party settled certain outstanding balances of his notes through issuance of the Company’s common stock, therefore, reducing the overall balance of the notes during the current period.

During the six months ended June 30, 2019, the Company recognized $187,128 of derivative expense, compared to $42,512 of derivative income for the six months ended June 30, 2020, an increase of ~~$738,~~$229,640, or ~~4%. Interest expense remained consistent because the Company had comparable amounts of convertible notes and notes payable to related parties outstanding during both periods.~~

During the three months ended March 31, 2019, the Company recognized $27,180 of derivative income, compared to $122,406 derivative income for the three months ended March 31, 2020, an increase of $95,226, or 350%123%. The increase in the amount of outstanding convertible notes payable with variable conversion feature that gave rise to derivative liability, coupled with the reduction in our share price during the current period gave rise to derivative income and its increase.

As a result of the changes described above, the Company incurred a net loss from continuing operations of ~~$198,357~~$612,319 for the ~~three~~six months ended ~~March 31,~~June 30, 2019, compared to a net loss from continuing operations of ~~$65,258~~$189,313 for the ~~three~~six months ended ~~March 31,~~June 30, 2020, ana decrease in the loss of ~~$133,099,~~$423,006, or ~~67%~~69%.

For the ~~three~~six months ended ~~March 31, 2019,~~June 30, 2020, the Company’s subsidiaries generated revenues of ~~$163,505~~$1,622 from operations as compared to ~~$1,622~~$304,229 for the ~~three~~six months ended ~~March 31, 2020, an~~June 30, 2019, a decrease of ~~$161,883~~$302,607, or 99%. The decrease ~~in revenues was primarily due to no extraction contracts in~~is a result of the ~~current period. The minimal revenues generated during the current period was from sale~~Company winding down of ~~hemp-infused products.~~its subsidiaries’ operations.

For the ~~three~~six months ended ~~March 31, 2019,~~June 30, 2020, the Company’s subsidiaries incurred costs of goods sold ~~was $72,199,~~of $110,103, compared to ~~$110,103~~$254,540 for the ~~three~~six months ended ~~March 31, 2020, an increase~~June 30, 209, a decrease of ~~$37,904,~~$144,437, or ~~52%~~57%. ~~Costs~~As a result of ~~goods sold was higher during~~winding down its operations, the subsidiaries incurred minimal costs related to production but continued to employ a workforce until it laid off its workers. During the current period, ~~is primarily due to (1)~~ the ~~write~~subsidiaries also wrote down ofits inventory ~~of $15,000~~ to its net realizable ~~value, and (2) an increase in depreciation in property and equipment.~~value.

As a result of the changes in revenues and costs of ~~goods~~good sold ~~discussed~~ above, the Company’s subsidiaries ~~gross margin decreased from~~incurred a ~~profit of $91,306, or 56% of revenues for the three months ended March 31, 2019 to a~~gross loss of $108,481 ~~or (6,688%) of revenues for~~during the ~~three~~six months ended ~~March 31, 2020. The decrease in~~June 30, 2020, compared to a gross profit ~~is primarily due to no extraction contracts.~~of $49,689 during the six months ended June 30, 2019, a decrease of $158,170, or 318%.

For the ~~three~~six months ended ~~March 31, 2019,~~June 30, 2020, selling, general and administrative expenses were ~~$90,414,~~$28,309, compared to ~~$28,309 during~~$145,855 for the ~~three~~six months ended ~~March 31, 2020,~~June 30, 2019, a decrease of ~~$62,105,~~$117,546, or ~~69%~~81%. The decrease ~~in these expenses~~ is ~~primarily attributable to a gradual lay off of our workforce and the wind down of these operations.~~

During the three months ended March 31, 2019, the Company’s subsidiaries incurred interest expense of $2,643, compared to $3,221 for the three months ended March 31, 2020, an increase of $578, or 22%. Interest expense remained consistent and it is attributabledue to the ~~subsidiaries’ finance lease obligation.~~subsidiaries winding down its operations and laying off its workforce.

As a result of the changes in revenues, costs and expenses, the Company’s subsidiaries ~~generated a~~incurred net ~~income~~loss from discontinued operations of ~~$332~~$140,353 for the ~~three~~six months ended ~~March 31, 2019,~~June 30, 2020, compared to a net loss from discontinued operations of ~~$140,354~~$95,620 for the ~~three~~six months ended ~~March 31, 2020, an decrease of $140,686, or 42,375%.~~June 30, 2019.

The Company’s cash position at ~~March 31,~~June 30, 2020 decreased by ~~$2,201~~$2,195 to ~~$415,~~$421, as compared to a balance of $2,616, as of December 31, 2019. The net decrease in cash for the ~~three~~six months ended ~~March 31,~~June 30, 2020 was primarily attributable to cash used by operating activities from increase in accounts payable and accrued expenses.

As of ~~March 31,~~June 30, 2020, the Company had negative working capital of ~~$1,375,299~~$658,848 compared to negative working capital of $1,475,211 at December 31, 2019, an increase of ~~$99,912,~~$816,363, attributable primarily to ~~reporting~~disposing its subsidiaries’ assets and liabilities from discontinued operations asduring the current ~~assets and current liabilities since these amounts are expected to be settled within the next twelve months.~~period.

Net cash used in operating activities of ~~$96,165~~$96,161 during the ~~three~~six months ended ~~March 31,~~June 30, 2020, was lower compared to the prior period of ~~$133,613,~~$286,745, primarily due to the wind down of the subsidiaries’ operations and an increase in accounts payable and accrued expenses during the current period.

Net cash provided by financing activities of $49,928 during the ~~three~~six months ended ~~March 31,~~June 30, 2020, decreased by ~~$41,272~~$158,272 compared to ~~$91,200~~$208,200 during the ~~three~~six months ended ~~March 31,~~June 30, 2019. In the current period, as the Company’s share price was decreasing, the Company turned to its related parties to generate cash flows from issuance of notes payable to related parties. In the prior period, the Company was able to generate cash flows through sale of its common ~~stock.~~stock and issuance of convertible notes payable.

During the ~~three~~six months ended ~~March 31,~~June 30, 2020, the Company issued shares of its common stock to settle ~~$72,200~~$107,050 of principle and accrued interest of its convertible notes payable and the related derivative liability of ~~$69,271.~~$101,763. The Company also issued a convertible note payable to settle accounts payable with certain vendors and issued Series B Convertible Preferred Stock valued at $1,475 as a result of a change in control. During the ~~three~~six months ended ~~March 31,~~June 30, 2019, the Company issued shares of its common stock to settle ~~$45,000~~$174,200 of principle and accrued interest of its convertible notes payable and the related derivative liability of ~~$41,933.~~$230,938. In addition, the Company also issued common stock to settle $8,000 of accrued expense with a related party and $122,984 of notes payable and accrued interest with a related party.

As reported in the accompanying consolidated financial statements, for the ~~three~~six months ended ~~March 31,~~June 30, 2020 and 2019, the Company incurred net losses from continuing operations of ~~$65,258~~$189,313 and ~~$198,357,~~$612,319, respectively. Management’s plan in this regard is to find new operations to enter into and focus on building profitable operations. To finance operations while it finds new operations, the Company will continue financing activity such as entering into loan agreements and issuing new shares of the Company’s common stock. Therefore, the Company expects to continue to incur operating losses and to incur professional fees to maintain its reporting company status. Until such time that the Company is able to generate revenue and become profitable or find new sources of capital, the Company will find it difficult to continue to meet its obligations as they come due. There can be no assurance that the Company will be successful in its efforts to raise capital, or if it were successful in raising capital, that it would be successful in meeting its business plans. Management’s plans include attempting to raise funds from the public through an equity offering of the Company’s common stock and identifying and developing new opportunities. However, the recent COVID-19 pandemic has presented unprecedented challenges to businesses and the investing landscape around the world. Therefore, there can be no assurance that ~~Management’s~~management’s plans will be successful.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from continuing operations for all periods presented and has a substantial accumulated deficit. As of ~~March 31,~~June 30, 2020, these factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

The Company’s subsidiaries cash position at March 31, 2020 decreased by $26,573 to $576, as compared to a balance of $27,149, as of December 31, 2019. The net decrease in cash for the three months ended March 31, 2020 was attributable to cash used by operating activities through cash collected from accounts receivable, offset by payments on accounts payable and accrued expenses.

As of March 31, 2020, the Company’s subsidiaries had assets of $507,774 and liabilities of $240,828. These assets and liabilities from discontinued operations are reported as current assets and current liabilities since these amounts are expected to be settled within the next twelve months.

Net cash used in operating activities of $20,756 during the three months ended March 31, 2020 decreased by $52,962 compared to the prior period of $73,718, primarily due to decrease in operating expenses during the current period as the Company was winding down the operations of the subsidiaries.

~~Net cash used in investing activities was $24,102 during the three months ended March 31, 2019.~~

Net cash used by financing activities of $3,293 during the three months ended March 31, 2020 increased by $99 compared to $3,194 during the three months ended March 31, 2019. The Company’s subsidiaries financing activities consisted of monthly payments of long-term debt and its finance lease obligations which remained consistent during the periods.

During the three months ended March 31, 2019, the Company’s subsidiaries acquired a finance lease by assuming a lease liability in the amount of $182,041. In addition, it acquired an operating lease by assuming a lease liability in the amount of $29,655.

The Company’s total assets at ~~March 31,~~June 30, 2020 was ~~$515,774,~~$4,755, compared to total assets at December 31, 2019 of $654,237, a decrease of ~~$138,463,~~$649,482, or ~~21%~~99%. As a result of discontinuing its subsidiaries operations, the Company reclassified $507,774 and ~~$129,367~~$646,445 of the subsidiaries total assets as ~~current~~ assets of discontinued operations on March 31, 2020 and December 31, 2019, respectively, and ~~$517,078~~disposed of them during the ~~subsidiaries assets as non-current assets of discontinued operations on December 31, 2019.~~three months ended June 30, 2020.

Total liabilities at ~~March 31,~~June 30, 2020 consisted of current liabilities of ~~$1,891,073~~$663,603 and derivative liability of ~~$189,653.~~$237,055. Total liabilities at December 31, 2019 consisted of current liabilities of $1,611,529 and long-term liabilities of $556,446, a decrease of ~~$87,249,~~$1,267,317, or 4%58%. As a result of discontinuing its subsidiaries operations, the Company reclassified $240,828 and ~~$160,347~~$335,463 of the subsidiaries liabilities as ~~current~~ liabilities of discontinued operations on March 31, 2020 and December 31, 2019, respectively, and ~~$175,116~~disposed of them during the ~~subsidiaries assets as non-current assets of discontinued operations on December 31, 2019.~~three months ended June 30, 2020.

The change in the Company’s financial condition is a result of ~~winding down~~discontinuing and disposing its subsidiaries operations in the ~~three~~six months ended ~~March 31,~~June 30, 2020. The ~~Company’s subsidiaries collected~~Company continues to incur professional fees in order to maintain its accounts receivable, suspended its investments in the farm and leasehold improvements, wrote down its inventory to its net realizable value, suspended payments to its vendors, increased its borrowings from related parties while the convertible note holders converted some of the notes into the Company’s common stock.reporting company status. As a result of these changes, the Company’s cash position of its continuing operations decreased from $2,616 on December 31, 2019 to ~~$415~~$421 on ~~March 31, 2020. In addition, the Company’s subsidiaries’ cash position of discontinued operations decreased from $27,149 on December 31, 2019 to $576 on March 31,~~June 30, 2020.

We have made no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

We are a Smaller Reporting Company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of ~~March 31,~~June 30, 2020. Based upon such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of ~~March 31,~~June 30, 2020, the Company’s disclosure controls and procedures were not effective. The controls were determined to be ineffective due to the lack of segregation of duties. In January 2017, the Company hired a part-time financial controller to assist with technical accounting issues and the preparation of the filings. However, until the Company begins generating sufficient revenues, it is unable to remediate the weakness. Despite the existence of material weaknesses, management believes the financial information presented herein is materially correct and fairly presents the financial position and operating results of the ~~three~~six months ended ~~March 31,~~June 30, 2020, in accordance with U.S. GAAP.

No change in the Company’s internal control over financial reporting occurred during the ~~three~~six months ended ~~March 31,~~June 30, 2020, that materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

The Company is a Smaller Reporting Company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and is not required to provide the information under this item.

During the ~~three~~six months ended ~~March 31,~~June 30, 2020, the Company issue ~~3,706,781~~12,897,956 shares of its restricted common stock as follows:

The shares of our common stock were issued pursuant to an exemption from registration in Section 4(a)(2) of the Securities Act of 1933. These shares of our common stock qualified for exemption under Section 4(a)(2) of the Securities Act of 1933 since the issuance of shares by us did not involve a public offering. The offering was not a “public offering” as defined in Section 4(a)(2) due to the insubstantial number of persons involved in the deal, size of the offering, manner of the offering and number of shares offered. We did not undertake an offering in which we sold a high number of shares to a high number of investors. In addition, these shareholders had necessary investment intent as required by Section 4(a)(2) since they agreed to receive share certificates bearing a legend stating that such shares are restricted pursuant to Rule 144 of the 1933 Act. This restriction ensures that these shares would not be immediately redistributed into the market and therefore not be part of a “public offering.” All shareholders are “sophisticated investors” and are business acquaintances of our officers and directors. Based on an analysis of the above factors, we believe we have met the requirements to qualify for exemption under section 4(a)(2) of the Securities Act of 1933 for this transaction.

3.1 Incorporated by reference herein from the Company’s Form 8-K filed on July 16, 2015.

3.2 Incorporated by reference herein from the Company’s Form 8-K filed on July 16, 2015.

9.0 Incorporated by reference herein from the Company’s Form 10-K filed on April 2, 2018.

10.1 Incorporated by reference herein from the Company’s Form 8-K filed on November 3, 2017.

10.2 Incorporated by reference herein from the Company’s Form 8-K filed on November 3, 2017.

10.3 Incorporated by reference herein from the Company’s Form 8-K filed on November 3, 2017.

10.4 Incorporated by reference herein from the Company’s Form 8-K filed on November 3, 2017.

10.5 Incorporated by reference herein from the Company’s Form 8-K filed on November 3, 2017.

10.6 Incorporated by reference herein from the Company’s Form 8-K filed on November 3, 2017.

10.7 Incorporated by reference herein from the Company’s Form 10-Q filed on November 5, 2018.

14.0 Incorporated by reference herein from the Company’s Form 10-Q filed on November 13, 2017.

21.0 Incorporated by reference herein from the Company’s Form 10-Q filed on August 7, 2017.

Pursuant to the requirements of the Securities exchange Act of 1934, registrant has duly caused this report to be signed on its behalf by the undersigned.

(Mark One)

☒	QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended ~~March 31,~~June 30, 2020

☐	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

	For the transition period from __________________ to ______________

Texas	75-2095676
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

704 Forest Glen Road, Silver Spring, MD	20901
(Address of principal executive offices)	(Zip Code)

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	ACCA	OTCQB

Large accelerated filer ☐		Accelerated filer ☐

Non-accelerated filer ☐		Smaller Reporting Company ☒

Emerging growth company ☐

		Page
PART I. Financial Information

Item 1.	Financial Statements	F-1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	5
Item 4.	Controls and Procedures	56

PART II. Other Information

Item 1.	Legal Proceedings	67
Item 1A.	Risk Factors	67
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	67
Item 3.	Defaults Upon Senior Securities	67
Item 4.	Mine Safety Disclosures	67
Item 5.	Other Information	67
Item 6.	Exhibits	78

Signatures		89

	Series B Convertible Preferred Stock				Common Stock
	Shares		Par Value		Shares		Par Value		Additional Paid-in Capital		Accumulated Deficit			Total
Balance December 31, 2019 (audited)		-	$	-		39,583,543	$	39,584	$	6,706,657	$	(8,259,979	)	$	(1,513,738	)

Common stock issued for services		-		-		272,000		272		5,659		-			5,931

Common stock issued for conversion of convertible note		-		-		12,585,956		12,586		94,464		-			107,050

Settlement of derivative liability from conversion of convertible note		-		-		-		-		101,763		-			101,763

Employee stock plan compensation		-		-		40,000		40		6,956		-			6,996

Issuance of preferred stock		1,475,000		1,475		-		-		-		-			1,475

Net income		-		-		-		-		-		394,620			394,620

Balance June 30, 2020 (unaudited)		1,475,000	$	1,475		52,481,499	$	52,482	$	6,915,499	$	(7,865,359	)	$	(895,903	)

Professional fees	$	110,000
Accounts payable		28,050
Accrued compensation to our former CEO		187,000
Accrued compensation to our former COO		91,000
Convertible notes		250,000
	$	666,050

	Fair Value Measurement at December 31, 2019 (1) Using Level 2
	Note 3		Note 4		Note 5		Total
Liability:
Derivative liability	$	111,928	$	129,833	$	139,569	$	381,330
Total liability	$	111,928	$	129,833	$	139,569	$	381,330

Date of Conversion of Note 4	Amounts Converted		Conversion Price		Number of Shares Issued
Principle conversion
May 7, 2020	$	4,900	$	0.0034		1,441,176
May 13, 2020	$	8,000	$	0.0034		2,352,941
May 14, 2020	$	8,400	$	0.0034		2,470,588

Total amount converted	$	21,300				6,264,706

Liabilities forgiven pursuant to the Acquisition Agreement
Accounts payable	$	5,476
Payable to related party		35,348
Notes payable to related parties		802,328
Accrued interest on notes payable to related parties		148,079
Total liabilities forgiven					991,231

Net assets of discontinued operations
Cash		574
Inventories		30,686
Prepaid expense and other current assets		558
Property & equipment, net of accumulated depreciation of $454,548		313,105
Deposits		3,810
ROU asset - finance lease, net of accumulated amortization of $18,598		159,040
Accounts payable and accrued expenses		(31,218	)
Long-term debt		(14,130	)
Lease liability - finance lease		(171,060	)
Payable to related parties		(24,420	)
Total net assets of discontinued operations					(266,945	)

Gain on disposition of net assets of discontinued operations				$	724,286

CURRENT ASSETS OF DISCONTINUED OPERATIONS:
Cash	$	27,149
Accounts receivable		52,461
Inventories (1)		46,197
Prepaid expenses and other current assets		3,560
Total Current Assets of Discontinued Operations		129,367

NON-CURRENT ASSETS OF DISCONTINUED OPERATIONS:
Property and equipment, net of accumulated depreciation of $417,144 in 2019 (2)		350,509
Deposits		3,810
ROU asset - finance lease, net of accumulated amortization of $14,879 in 2019 (3)		162,759
Total Non-Current Assets of Discontinued Operations		517,078

TOTAL ASSETS OF DISCONTINUED OPERATIONS	$	646,445

CURRENT LIABILITIES OF DISCONTINUED OPERATIONS:
Accounts payable and accrued expenses (4)	$	113,560
Current portion of long-term debt (5)		4,359
Current portion of lease liability - finance lease (3)		9,008
Payable to related parties (6)		33,420
Total Current Liabilities of Discontinued Operations		160,347

LONG-TERM LIABILITIES OF DISCONTINUED OPERATIONS:
Long-term debt (5)		10,861
Lease liability - finance lease (3)		164,255
Total Long-term Liabilities of Discontinued Operations		175,116

TOTAL LIABILITIES OF DISCONTINUED OPERATIONS	$	335,463

Right of use (ROU) asset - operating lease obtained in exchange for lease liability - operating lease
	$	29,355
Amortization of ROU asset - operating lease		(29,355	)
ROU asset - operating lease at December 31, 2019	$	0

Lease liability - operating lease on adoption date	$	29,655
Payments on lease liability - operating lease		(29,655	)
Lease liability - operating lease on December 31, 2019	$	0

This entire lease liability matured on November 30, 2019

Operating lease expense for the year ended December 31, 2019	$	28,125
Weighted average remaining lease term		-
Weighted average discount rate		5.99	%

	1.	The lease is with a related party of the Company.
	2.	Although the initial lease term is for one year, the Company is reasonably certain to acquire the property from the related party.
	3.	Contrary to leases with fixed lease payments, this lease requires the Company to pay all expenses related to the acquisition and operations of the property which are variable. Although the Company can exclude variable lease payments in applying ASC 842, the lease provides the necessary cash flows for the related party to service his debt. Therefore, the Company estimates future incremental borrowing costs to be incurred by the related party when measuring the initial finance lease liability. This amounts to approximately $1,600 per month.
	4.	The related party's debt term was 15 years at a borrowing rate of 5.99%
	5.	The Company considered the most objective measure of the right-of-use asset to be the purchase price paid by the related party for the property. The purchase price is then allocated among land and improvement and the Company amortizes the improvement over the estimated useful life of 10 years.

Amounts of lease liability - finance lease matures over the next five years:
Twelve Months Ended March 31,
2021	$	9,140
2022		9,687
2023		10,268
2024		10,883
2025 and thereafter		131,082
	$	171,060

~~Variable lease expense was $9,671 and $7,720, for the three months ended March 31, 2020 and 2019, respectively.~~
~~Weighted average remaining lease term~~	~~13 years~~
~~Weighted average discount rate~~		~~5.99~~	%

	June 30, 2020			December 31, 2019
Short term loan from related entity (a)	$	24,420		$	33,420
	$	24,420		$	33,420
Payable to related parties disposed of during the three months ended June 30, 2020		(24,420	)		-
Payable to related parties from discontinued operations	$	-		$	33,420

Exhibit Number and Description				Location Reference

	(3.0)	Articles of Incorporation
		(3.1)	Articles Of Amendment And Restated Articles Of Incorporation of Acacia Diversified Holdings, Inc. dated June 9, 2015	See Exhibit Key
		(3.2)	Restated Bylaws Of Acacia Diversified Holdings, Inc. dated June 29, 2015	See Exhibit Key
	(9.0)	Voting Proxy Agreement between Rick Pertile and Steven L. Sample		See Exhibit Key
	(10.1)	Consolidated Loan Agreement		See Exhibit Key
	(10.2)	Consolidated Promissory Note		See Exhibit Key
	(10.3)	Security Agreement – Acacia Diversified Holdings, Inc.		See Exhibit Key
	(10.4)	Security Agreement -- Marij Agriculture, Inc.		See Exhibit Key
	(10.5)	Security Agreement – Marij Pharmaceuticals, Inc.		See Exhibit Key
	(10.6)	Security Agreement – CannaCures Research & Development Center, Inc.		See Exhibit Key
	(10.7)	Definitive Asset Purchase Agreement between Acacia Diversified Holdings, Inc. and the Medahub Companies		See Exhibit Key
	(14.0)	Code of Ethics		See Exhibit Key
	(21.0)	List of Subsidiaries		See Exhibit Key
	(31.1)	Certificate of Chief Executive Officer And Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002		Filed herewith
	(32.1)	Certification of Chief Executive Officer And Chief Financial Officer Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002		Filed herewith
	101.INS	XBRL Instance Document
	101.SCH	XBRL Taxonomy Extension Schema Document
	101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
	101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
	101.LAB	XBRL Taxonomy Extension Label Linkbase Document
	101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

	Acacia Diversified Holdings, Inc.

Date: August 7,19, 2020	By:	/s/ Jeffrey D. Bearden
		Jeffrey D. Bearden
		Principal Executive Officer
		Principal Financial Officer